Grashma Vadakkel, PharmD, BCOP

Bone Marrow Transplant Clinical Pharmacy Specialist at Memorial Sloan Kettering Cancer Center | PGY1 @NebraskaMed & PGY2 @Sloan_Kettering | Views are my own

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

Interested in completing a #PGY2 Pharmacy Residency at MSK?

MSK will host virtual info sessions for PGY2 Pharmacy Residency Programs on Tuesday, 11/19. Learn more about MSK's #pharmacy programs & have the opportunity to meet program directors. Register: https://t.co/d9nsqStJf9

[moneeza @wanderingmd]

too all the wonderful Pharm Ds I have encountered in my life, especially those on BMT @MSK_DeptOfMed, thank you. I hope we can remain team mates. @GrayVPharmD @SEngPharmD @MaryNauffal @APharmDLin and others!

[Liz Rogers @lizrogers22]

🚨🚨 📢 the data we’ve all been waiting for…drum roll please 👏👏👏 letermovir use til D+200 was shown to be safe & effective in HSCT pt post txp in recent phase 3 RCT‼️ So excited to have this extra data to support use beyond D+100 in this high risk pop! 🎉🎉🎉 #Tandem23 @ASTCT

[Grashma Vadakkel, PharmD, BCOP @GrayVPharmD]

February 17th is #GVHDday #Tandem23 #GVHDconnect4Hope @SEngPharmD @ASTCT @CIBMTR

[Stephen Eng, PharmD, BCOP @SEngPharmD]

Come stop by our poster (461) at 5:45pm later today in Magnolia 19! “Insurance Barriers to High-Cost Anti-infective Medications post Allo-HCT” #Tandem23 @GrayVPharmD @GunjanLShah @DrMiguelPerales @ASTCT @CIBMTR

[Stephen Eng, PharmD, BCOP @SEngPharmD]

Having a great time at #Tandem23 @ASTCT @CIBMTR @GrayVPharmD

[NYCSHP @NYCSHP]

Our June Spotlight✨ is Dr. @GrayVPharmD PharmD, BCOP! She serves as our NYCSHP Installation Chair for 2021-2022  💊. Thank you for your involvement and contributions to our chapter and pharmacy practice! ���

[Grashma Vadakkel, PharmD, BCOP @GrayVPharmD]

@HanjieRx Thank you, @HanjieRx !

[Grashma Vadakkel, PharmD, BCOP @GrayVPharmD]

A milestone in professional development. Happy (and relieved) to have passed the Oncology Certification Exam. And even more excited to be a Board Certified Oncology Pharmacist!

#oncology #healthcare #oncopharm #bps

[Stephen Eng, PharmD, BCOP @SEngPharmD]

Co-residents who vaccinate together stay together 💉 Grateful to receive the vaccine! @GrayVPharmD @RayDPharmD @JillGPharmD #OncoPharm

[NEJM @NEJM]

Safety and Efficacy of the BNT162b2 COVID-19 Vaccine 

#COVID19 #IDTwitter

[Grashma Vadakkel, PharmD, BCOP @GrayVPharmD]

@HanjieRx @sloan_kettering @ClevelandClinic @LarryBuie @SEngPharmD Welcome to the team!

[Grashma Vadakkel, PharmD, BCOP @GrayVPharmD]

I had no idea about stem cell transplant until 3 years ago. On the first day of my 4th year BMT rotation, I got grilled so hard, knew nothing, went home & cried because I thought I was going to fail.

Today I’m a BMT pharmacy specialist & I love it.

Funny where life takes you.

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

ICYMI: MSK is proud to be named one of the top cancer centers in the nation. Learn more about our world-class cancer care and breakthroughs. @usnews #besthospitals https://t.co/oagnkG85d3

[Grashma Vadakkel, PharmD, BCOP @GrayVPharmD]

@MScordoMD @SEngPharmD Thank you, Dr. Scordo!

[Stephen Eng, PharmD, BCOP @SEngPharmD]

First day on the new job as Bone Marrow Transplant Clinical Pharmacy Specialists! @GrayVPharmD #MSK #Coresidents

[MSKHemOncTrials @MSKHemOncTrials]

Congratulations & we look fwd to working with you on @sloan_kettering BMT Service

[Grashma Vadakkel, PharmD, BCOP @GrayVPharmD]

10+ years, 3 degrees, 2 residencies, and a dream job offer later...

I have officially graduated from @sloan_kettering PGY2 Adult Oncology Residency Program. I am even more excited to be staying on as a BMT Clinical Pharmacy Specialist!

I’m happy. I’m incredibly grateful.

[FDA Oncology @FDAOncology]

FDA approved Retevmo (selpercatinib) to treat non-small cell lung cancer and thyroid cancers in patients whose tumors have a RET gene mutation or fusion. Retevmo is the 1st therapy approved specifically for cancer with RET gene alterations. #lcsm #thycsm
https://t.co/fhNUOF4DMo

[Raymond DeMatteo, PharmD, BCOP @RayDPharmD]

Exciting to see targeted MET therapies become available to patients with NSCLC!